ResearcherState Research Institute Centre for Innovative MedicineActive in the last 2 years
Julita Kulbacka
Matched on ORCID iD 0000-0001-8272-5440; OpenAlex author ID A5008935240. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 3, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 10
- Delivery of Ulva rigida extract by bicontinuous cubic lipid nanoplatforms for potential photodynamic therapy against pancreatic cancer. First author DOI 10.1016/j.colsurfb.2025.114754↗
- Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer. Last author DOI 10.1038/s41598-023-27605-4↗
- Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method. Last author DOI 10.3390/ijms24054381↗
- The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance proteins. Last author DOI 10.1016/j.bioelechem.2022.108199↗
- Predicting the chemosensitivity of pancreatic cancer cells as a personalized therapy. Last author DOI 10.17219/acem/152809↗
- New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporat… Last author DOI 10.1016/j.suronc.2021.101634↗
- Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation on quality of life and progression-free survival in patients with pan… Last author DOI 10.17219/acem/139917↗
- Electroporation with Cisplatin against Metastatic Pancreatic Cancer: In Vitro Study on Human Primary Cell Culture. First author DOI 10.1155/2018/7364539↗
- The favourable effect of catechin in electrochemotherapy in human pancreatic cancer cells. Last author DOI 10.18388/abp.2018_2602↗
- Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma. First author DOI 10.5114/pg.2016.61438↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Julia Rudno-Rudzińska · 4 shared papers, 2021–2023 · strength 0.79
- Paper Predicting the chemosensitivity of pancreatic cancer cells as a personalized therapy. DOI 10.17219/acem/152809↗
- Paper Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method. DOI 10.3390/ijms24054381↗
- Paper Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation on quality of life and progre… DOI 10.17219/acem/139917↗
- Olga Michel · 5 shared papers, 2018–2023 · strength 0.78
- Paper Predicting the chemosensitivity of pancreatic cancer cells as a personalized therapy. DOI 10.17219/acem/152809↗
- Paper The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance… DOI 10.1016/j.bioelechem.2022.108199↗
- Paper Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer. DOI 10.1038/s41598-023-27605-4↗
- Jolanta Saczko · 5 shared papers, 2016–2023 · strength 0.65
- Paper The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance… DOI 10.1016/j.bioelechem.2022.108199↗
- Paper Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer. DOI 10.1038/s41598-023-27605-4↗
- Paper Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma. DOI 10.5114/pg.2016.61438↗
- Wojciech Szlasa · 2 shared papers, 2022–2023 · strength 0.37
- Paper The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance… DOI 10.1016/j.bioelechem.2022.108199↗
- Paper Nanosecond pulsed electric field suppresses growth and reduces multi-drug resistance effect in pancreatic cancer. DOI 10.1038/s41598-023-27605-4↗
- Urszula Bazylińska · 1 shared paper, 2025 · strength 0.24
- Karolina Krautforst · 1 shared paper, 2025 · strength 0.24
- Agnieszka Gajewska-Naryniecka · 1 shared paper, 2023 · strength 0.22
- Olga Wysocka · 1 shared paper, 2016 · strength 0.10
- Adam Rzechonek · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.